Skip to main navigation Skip to search Skip to main content

Expanded Access Program of VX 770

Project: Research

Project Details

StatusFinished
Effective start/end date07/19/1103/7/13

Funding

  • Vertex Pharmaceuticals Incorporated: $9,240.00